About this trial
The objective of this study is to examine photos of CCCA patients taken before and after treatment to compare treatment outcomes between different treatment groups
Eligibility criteria
Qualifiers
African-American women, ages 18-60 years old
with a clinical diagnosis and biopsy-proven CCCA, with Central Scalp Alopecia Scale severity 1 through 4 will be included in this study
These subjects will be seen and treated in Wake Forest Baptist Health Dermatology Outpatient Clinic
Disqualifiers
Patients with other forms of hair loss in addition to CCCA will be excluded
Other patients to be excluded are those with other forms of inflammatory scalp disease (with the exception of mild seborrheic dermatitis)
patients who have had topical treatment for CCCA within the past 4 months (including topical steroids, topical minoxidil, or any other topical hair regrowth medication)
patients who have been on a long-term oral antibiotics for hair loss within the past year
Trial design
Treatments tested in this trial
- Topical steroid class I-II
- Triamcinolone Acetonide
- Doxycyline
- Minoxidil
Treatment groups
Sponsors and collaborators
Wake Forest University Health Sciences
Lead sponsor
The Skin of Color Society
Collaborator